Celltrion
068270.KS
#861
Rank
โ‚น2.739 T
Marketcap
โ‚น12,542
Share price
4.80%
Change (1 day)
36.82%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น181.19. an increase over its 2024 EPS that were of โ‚น117.81.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025โ‚น310.61163.66%
2024โ‚น117.81-53.73%
2023โ‚น254.62-2.08%
2022โ‚น260.03-11.72%
2021โ‚น294.552.03%
2020โ‚น288.6782.8%
2019โ‚น157.9118.31%
2018โ‚น133.48-36.33%
2017โ‚น209.65161.25%
2016โ‚น80.252.86%
2015โ‚น78.0217.84%
2014โ‚น66.215.87%
2013โ‚น62.53-70.85%
2012โ‚น214.53134.09%
2011โ‚น91.6443.59%
2010โ‚น63.8274.49%
2009โ‚น36.58317.8%
2008โ‚น8.75-71.7%
2007โ‚น30.93